期刊文献+

穿心莲内酯增溶制剂技术的研究进展 被引量:2

Research progress on solubilizing pharmaceutical technology of andrographolide
下载PDF
导出
摘要 穿心莲内酯是中药穿心莲的主要药效成分之一,具有多种药理活性,目前临床上常用于感染性疾病的治疗。然而,穿心莲内酯水溶性不佳,口服生物利用度低,导致其体内分布和累积较少。通过查阅国内外文献,本文就应用于穿心莲内酯增溶的制剂技术进行综述,包括固体分散技术、超微粉碎技术、环糊精包合技术和纳米制剂技术等,为其进一步开发利用提供依据。 Andrographolide is a bioactive diterpenoid lactone compound from a traditional medicinal herb Chuanxinlian.Andrographolide has anti-inflammatory,anti-viral,liver-protecting,anti-tumor and other pharmacological effects.It is extensively used for infectious diseases.However,andrographolide has poor water solubility and low bioavailability,which limited its distribution and accumulation in the body after administration.This paper reviews research advance of pharmaceutical technologies which can increase the solubility of andrographolide from home and abroad,including solid dispersion technology,superfine grinding technology,inclusion technology of cyclodextrin and nanotechnology,to provide reference for the development and utilization of Andrographolide.
作者 刘业茂 王娴 龙家英 谢龙 孙强 李小芳 LIU Ye-mao;WANG Xian;LONG Jia-ying;XIE Long;SUN Qiang;LI Xiao-fang(Huaiyin People's Hospital,Pharmacy Department,Jinan 250000,Shandong;School of Pharmacy,Chengdu Universty of Traditional Chinese Medicine,Key Laboratony of Standardization for Chinese Herbal Medicine,Ministry of Education,National Key Laboratory Breeding Base of Systematic Research,Development and Uilization of Chinese Medicine Resources,Chengdu 611137,Sichuan)
出处 《中药与临床》 2019年第5期75-78,F0003,共5页 Pharmacy and Clinics of Chinese Materia Medica
基金 基于“药效组分-粒子复合”模式纳米复合粒子的制备及其稳态增效机制的研究,2019YFS0113。
关键词 穿心莲内酯 增溶 研究进展 Andrographolide solubilizing rescarch progress
  • 相关文献

参考文献47

二级参考文献455

共引文献422

同被引文献80

引证文献2

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部